Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 343

1.

Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine.

Little SF, Ivins BE, Fellows PF, Pitt ML, Norris SL, Andrews GP.

Vaccine. 2004 Jan 2;22(3-4):422-30.

PMID:
14670324
2.

Effect of aluminum hydroxide adjuvant and formaldehyde in the formulation of rPA anthrax vaccine.

Little SF, Ivins BE, Webster WM, Norris SL, Andrews GP.

Vaccine. 2007 Apr 12;25(15):2771-7. Epub 2007 Jan 2.

PMID:
17240008
3.

Duration of protection of rabbits after vaccination with Bacillus anthracis recombinant protective antigen vaccine.

Little SF, Ivins BE, Webster WM, Fellows PF, Pitt ML, Norris SL, Andrews GP.

Vaccine. 2006 Mar 24;24(14):2530-6. Epub 2005 Dec 27.

PMID:
16417950
4.

Intranasal administration of dry powder anthrax vaccine provides protection against lethal aerosol spore challenge.

Huang J, Mikszta JA, Ferriter MS, Jiang G, Harvey NG, Dyas B, Roy CJ, Ulrich RG, Sullivan VJ.

Hum Vaccin. 2007 May-Jun;3(3):90-3. Epub 2007 May 13.

PMID:
17375001
5.

Efficacy of recombinant anthrax vaccine against Bacillus anthracis aerosol spore challenge: preclinical evaluation in rabbits and Rhesus monkeys.

Chawla A, Midha S, Bhatnagar R.

Biotechnol J. 2009 Mar;4(3):391-9. doi: 10.1002/biot.200800213. Erratum in: Biotechnol J. 2009 May;4(5):599.

PMID:
19296443
6.

An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.

Wimer-Mackin S, Hinchcliffe M, Petrie CR, Warwood SJ, Tino WT, Williams MS, Stenz JP, Cheff A, Richardson C.

Vaccine. 2006 May 1;24(18):3953-63. Epub 2006 Feb 28.

PMID:
16530302
7.

In vitro correlate of immunity in a rabbit model of inhalational anthrax.

Pitt ML, Little SF, Ivins BE, Fellows P, Barth J, Hewetson J, Gibbs P, Dertzbaugh M, Friedlander AM.

Vaccine. 2001 Sep 14;19(32):4768-73.

PMID:
11535328
8.

Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants.

Berthold I, Pombo ML, Wagner L, Arciniega JL.

Vaccine. 2005 Mar 14;23(16):1993-9.

PMID:
15734073
9.

Comparative vaccine efficacy of different isoforms of recombinant protective antigen against Bacillus anthracis spore challenge in rabbits.

Ribot WJ, Powell BS, Ivins BE, Little SF, Johnson WM, Hoover TA, Norris SL, Adamovicz JJ, Friedlander AM, Andrews GP.

Vaccine. 2006 Apr 24;24(17):3469-76. Epub 2006 Feb 21.

PMID:
16519970
10.

Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers.

McBride BW, Mogg A, Telfer JL, Lever MS, Miller J, Turnbull PC, Baillie L.

Vaccine. 1998 May;16(8):810-7.

PMID:
9627938
11.

A single immunization with a dry powder anthrax vaccine protects rabbits against lethal aerosol challenge.

Klas SD, Petrie CR, Warwood SJ, Williams MS, Olds CL, Stenz JP, Cheff AM, Hinchcliffe M, Richardson C, Wimer S.

Vaccine. 2008 Oct 9;26(43):5494-502. doi: 10.1016/j.vaccine.2008.07.062. Epub 2008 Aug 12.

12.

Induction of protective immunity against lethal anthrax challenge with a patch.

Kenney RT, Yu J, Guebre-Xabier M, Frech SA, Lambert A, Heller BA, Ellingsworth LR, Eyles JE, Williamson ED, Glenn GM.

J Infect Dis. 2004 Aug 15;190(4):774-82. Epub 2004 Jul 13.

PMID:
15272406
13.

A synthetic peptide vaccine directed against the 2ß2-2ß3 loop of domain 2 of protective antigen protects rabbits from inhalation anthrax.

Oscherwitz J, Yu F, Cease KB.

J Immunol. 2010 Sep 15;185(6):3661-8. doi: 10.4049/jimmunol.1001749. Epub 2010 Aug 9.

14.

Development of an in vitro-based potency assay for anthrax vaccine.

Little SF, Webster WM, Ivins BE, Fellows PF, Norris SL, Andrews GP.

Vaccine. 2004 Jul 29;22(21-22):2843-52.

PMID:
15246620
15.

Mouse model characterisation for anthrax vaccine development: comparison of one inbred and one outbred mouse strain.

Flick-Smith HC, Waters EL, Walker NJ, Miller J, Stagg AJ, Green M, Williamson ED.

Microb Pathog. 2005 Jan;38(1):33-40. Epub 2004 Dec 19.

PMID:
15652293
16.

Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids.

Enkhtuya J, Kawamoto K, Kobayashi Y, Uchida I, Rana N, Makino S.

Microbiology. 2006 Oct;152(Pt 10):3103-10.

PMID:
17005989
17.

A plant-produced protective antigen vaccine confers protection in rabbits against a lethal aerosolized challenge with Bacillus anthracis Ames spores.

Chichester JA, Manceva SD, Rhee A, Coffin MV, Musiychuk K, Mett V, Shamloul M, Norikane J, Streatfield SJ, Yusibov V.

Hum Vaccin Immunother. 2013 Mar;9(3):544-52. Epub 2013 Jan 16.

18.

Protective activity and immunogenicity of two recombinant anthrax vaccines for veterinary use.

Fasanella A, Tonello F, Garofolo G, Muraro L, Carattoli A, Adone R, Montecucco C.

Vaccine. 2008 Oct 23;26(45):5684-8. doi: 10.1016/j.vaccine.2008.08.026. Epub 2008 Sep 4.

PMID:
18775462
20.

Efficacy and immunogenicity of single-dose AdVAV intranasal anthrax vaccine compared to anthrax vaccine absorbed in an aerosolized spore rabbit challenge model.

Krishnan V, Andersen BH, Shoemaker C, Sivko GS, Tordoff KP, Stark GV, Zhang J, Feng T, Duchars M, Roberts MS.

Clin Vaccine Immunol. 2015 Apr;22(4):430-9. doi: 10.1128/CVI.00690-14. Epub 2015 Feb 11.

Supplemental Content

Support Center